Prostate cancer: Oncorad place Morocco on the global map of innovative techniques

Meanwhile,

Prostate cancer: oncorad place morocco:

In the morning: Can you explain to us what is precisely the published study. Furthermore, what makes it a notable advance?

Dr Hamza Samlali:

Our research focuses on the association of external radiotherapy. For example, curiousherapy in the treatment of localized prostate cancer. Therefore, This combination allows a “climbing of dose”-that is to say a targeted increase in the dose of radiation on. In addition, the tumor-while preserving the healthy organs. Nevertheless, It is the major trend of the last decade: the higher the dose in the disease. Similarly, the more effective long -term control. For example, Thanks to the dose gradient offered by curiousherapy. Similarly, we can deliver very large doses in the sick area while limiting the exposure of neighboring fabrics. Moreover, Our results join those of the best international teams. Meanwhile, placing Morocco among the countries capable of practicing this advanced prostate cancer: oncorad place morocco technique, particularly indicated for cancers located with high potential for aggressiveness. Furthermore,

Dr Hamza Samlali

What are the concrete advantages of this combined treatment compared to conventional approaches?

Three reference studies – English. American (Ascend) and Canadian – have shown that dose climbing better protects patients at 10 or 15 years against recurrence and, in some cases, sterilize prostate. In addition. using high -flow dose techniques, the tolerance profile for high -flow dose curiousherapy is better than that of conventional treatments. Today, the external-curetherapy radiotherapy combination is considered the best method to achieve this level of precision and efficiency.

What type of patient has this method been tested?

We have treated patients with localized prostate cancer. without metastases, but with aggression factors: unfavorable prostate cancer: oncorad place morocco intermediate groups, high risk and very high risk of progression. These are difficult forms to treat by radiotherapy alone, with a risk of recurrence of up to 50% to 5 or 10 years. Our results confirm that this technique considerably reduces this risk.

What does this publication for Oncorad Group represent?

It is an international recognition of the scientific and methodological quality of our work. “Advances in radiation oncology”

is published by Astro (American Society for Radiation ONCOLOGY), a world reference. This success is the fruit of an academic partnership between Oncorad Group. the Casablanca University Hospital, with Pr Hassan Jouhadi, a major figure in radiotherapy in North Africa. This illustrates the importance of synergies between public and private prostate cancer: oncorad place morocco structures.

It is a first for an African and Arab center. Can we see a turning point for clinical research in the region?

Yes. This work shows that it is possible. from Morocco, to publish in strong impact magazines and to rise to the best world teams. We hope that this will inspire other teams in Africa. the Middle East/North Africa (MENA) region to engage in ambitious and collaborative research projects.

Is this technique already integrated into your care protocols? Is it reproducible elsewhere?

It is already practiced in three of our centers in Morocco. including that of Tangier, and several dozen patients have benefited. It is quite reproducible in countries with limited or intermediate resources. We are open to share our experience with other structures in Africa and the Middle East.

What are the next steps in your research?

We are working on catch -up curious therapy for patients in recurrence after conventional external radiotherapy. prostate cancer: oncorad place morocco Several of them have already obtained prolonged remission. In addition. our study on combined technique has become multicenter within Oncorad, which will further strengthen the scientific value of our work. We are planning new publications in the months and years to come.

Prostate cancer: oncorad place morocco

What is curiousherapy?

Curiahot therapy is a cancer treatment technique which consists in placing directly inside. in contact with the tumor a radioactive source. In the case of prostate cancer. fine applicators are inserted in a targeted manner, making it possible to deliver high doses of radiation at the heart of the sick area while preserving the neighboring organs and tissues.

There are two main types of curiousherapy:

• Low dose flow: Sources located continuously for several days.

• Dose high speed: short and intense sessions, very precise, limiting side effects.

Thanks to this millimeter targeting. curiousherapy is today one of the most effective methods for treating certain prostate cancer: oncorad place morocco localized cancers, including prostate, cervix or breast.

External radiotherapy explained

External radiotherapy uses high energy rays produced by a linear accelerator to destroy cancer cells. The beams are directed from outside the body, with a treatment plan made from medical images (CT, MRI).

Modern techniques. such as conformational radiotherapy or IMRT (conformational radiotherapy with intensity modulation), make it possible to adapt the radiation dose to the exact form of the tumor, thus reducing the exposure of healthy tissues. When associated with curiousherapy. it offers a double advantage: processing the tumor with a higher overall dose and improving the chances of healing while maintaining a good tolerance profile.

var settimeout_value = 4000. var initiate = 1, flag =1; function initialize(){ if(initiate==1){ initiate = 0; const loadScript = (src,async=false,timeout=0,skip_script = 0) => { if(skip_script==1){ return true; } return new Promise((resolve, reject) => { setTimeout(function(){ const script = document.createElement(‘script’); script.type=”text/javascript”; script.onload = resolve; prostate cancer: oncorad place morocco script.onerror = reject; script.defer = false; script.src = src; script.async = async; document.head.append(script); },timeout) }) }; const loadManualScript = () => { return new Promise((resolve, reject) => { var script_fb = document.createElement(‘script’); script_fb.src=”https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v10.0&appId=831585710912282&autoLogAppEvents=1″; script_fb.setAttribute(‘nonce’,’BlRghIV6′); script_fb.crossOrigin = ‘anonymous’ script_fb.setAttribute(‘async’, ‘async’); script_fb.setAttribute(‘defer’, ‘defer’); var readspeaker = document.createElement(‘script’); readspeaker.src=”https://cdn-eu.readspeaker.com/script/13066/webReader/webReader.js?pids=wr”; readspeaker.type=”text/javascript”; readspeaker.id = ‘rs_req_Init’; document.getElementsByTagName(‘HEAD’).item(0).appendChild(script_fb); document.getElementsByTagName(‘HEAD’).item(0).appendChild(readspeaker); }) }; loadScript(‘/js/lazyload.min.js?v=1’) .then(() => loadScript(‘https://lematin.ma/theme_lematin/js/initial.min.js?v=1.36’)) .then(() => loadScript(‘https://lematin.ma/theme_lematin/js/general-scripts.js?v=1.36’)) .then(() => loadScript(‘https://securepubads.g.doubleclick.net/tag/js/gpt.js’)) .then(() => loadScript(‘https://cdn.onesignal.com/sdks/OneSignalSDK.js’)) .then(() => loadManualScript()) .catch(() => console.error(‘Something went wrong.’)); var script_tagmanager = document.createElement(‘script’); var content_mgt = document.createTextNode(“(function(w, d, s, l, i) {w[l] = w[l] || [];w[l].push({‘gtm.start’: new Date().getTime(),event: ‘gtm.js’});var f = d.getElementsByTagName(s)[0],j = d.createElement(s),dl = l != ‘dataLayer’ ? ‘&l=” + l : “‘;j.async = true;j.src=”https://www.googletagmanager.com/gtm.js?id=” + i + dl;f.parentNode.insertBefore(j, f);})(window, document, ‘script’, ‘dataLayer’, ‘GTM-M5R4DJX’);”); script_tagmanager.appendChild(content_mgt); var noscript_tagmanager = document.createElement(‘noscript’); var noscript_iframe = document.createElement(‘iframe’); noscript_iframe.setAttribute(“height”, “0”); noscript_iframe.setAttribute(“width”, “0”); noscript_iframe.setAttribute(“style”,”display:none;visibility:hidden”); noscript_iframe.src=”https://www.googletagmanager.com/ns.html?id=GTM-M5R4DJX”; noscript_tagmanager.appendChild(noscript_iframe); document.getElementsByTagName(‘HEAD’).item(0).appendChild(script_tagmanager); document.getElementsByTagName(‘BODY’).item(0).prepend(noscript_tagmanager); var video_script_one = document.createElement(‘script’); video_script_one.type=”text/javascript”; video_script_one.src=”https://s1.lematin.ma/cdn/invideoads/videoloader_minified.js?v=1.4.6″; document.getElementsByTagName(‘HEAD’).item(0).appendChild(video_script_one); var video_script_two = document.createElement(‘script’); prostate cancer: oncorad place morocco video_script_two.async = true; video_script_two.type=”text/javascript”; video_script_two.src=”https://s1.lematin.ma/cdn/dfp/videojs/banderole_minified.js?v=1.4.6″; document.getElementsByTagName(‘BODY’).item(0).appendChild(video_script_two); setTimeout(function () { if($(‘body’).hasClass(‘habillage’)){ $(‘#newDivInParent’).css({‘display’:’block’,’top’: ($(‘.matin-articles-widget-homepage’).offset().top – 150) + ‘px’}) } }, 2500); } } settimeout_value = 3000; document.addEventListener(“mousemove”, initialize, {passive: true}); document.addEventListener(“scroll”, initialize, {passive: true}); document.addEventListener(“touchstart”, initialize, {passive: true}); setTimeout(function(){ initialize(); OneInitialize(); window.OneSignal = window.OneSignal || []; OneSignal.push(function() { OneSignal.init({ appId: “7d2358bb-c63c-4753-94b1-3c630eb6d90e”, serviceWorkerParam: { scope: “https://lematin.ma/” }, serviceWorkerPath: “/OneSignalSDKWorker.js”, }); }); },settimeout_value); function OneInitialize(){ if(flag == 1) { flag = 0; if (typeof (LazyLoad) === ‘undefined’) { $.getScript(‘https://lematin.ma/js/lazyload.min.js’, function () { setTimeout(function () { new LazyLoad({threshold: 0}); }, 100) }); } else { new LazyLoad({threshold: 0}); } } }

Prostate cancer: oncorad place morocco

Further reading: Historically low mortality in France in 2023, the PACA region particularly sparedNew HAS recommendationsPersonalization of the prevention of endometrial cancer through a diet and a lifestyleLama antibodies: new therapeutic track against schizophreniaFlu: A bill provides for the vaccination obligation for caregivers | Nurses.com | IDE profession.

Comments (0)
Add Comment